Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000794274 | SCV000933670 | pathogenic | not provided | 2018-09-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in LAMC2 are known to be pathogenic (PMID: 11907499, 16473856). This variant has been observed to be homozygous in an individual affected with junctional epidermolysis bullosa (PMID: 10951251). ClinVar contains an entry for this variant (Variation ID: 14557). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Cys553*) in the LAMC2 gene. It is expected to result in an absent or disrupted protein product. |
OMIM | RCV002051624 | SCV000035923 | pathogenic | Epidermolysis bullosa, junctional 3B, severe | 2000-08-01 | no assertion criteria provided | literature only |